Poseida Therapeutics, Inc. Quarterly Current Ratio in % from Q1 2021 to Q3 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Poseida Therapeutics, Inc. quarterly Current Ratio history and growth rate from Q1 2021 to Q3 2024.
  • Poseida Therapeutics, Inc. Current Ratio for the quarter ending September 30, 2024 was 282 %, a 38% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 282 -173 -38% Sep 30, 2024
Q2 2024 283 -270 -48.8% Jun 30, 2024
Q1 2024 327 -211 -39.3% Mar 31, 2024
Q4 2023 393 -122 -23.7% Dec 31, 2023
Q3 2023 454 -43.6 -8.75% Sep 30, 2023
Q2 2023 553 +77.5 +16.3% Jun 30, 2023
Q1 2023 539 -23.7 -4.21% Mar 31, 2023
Q4 2022 515 -177 -25.5% Dec 31, 2022
Q3 2022 498 -352 -41.4% Sep 30, 2022
Q2 2022 476 -507 -51.6% Jun 30, 2022
Q1 2022 562 -389 -40.9% Mar 31, 2022
Q4 2021 692 Dec 31, 2021
Q3 2021 850 Sep 30, 2021
Q2 2021 983 Jun 30, 2021
Q1 2021 952 Mar 31, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.